Skip to main content
OpenTrials
Completed

NCT Number: NCT05022602

Clinical Evaluation of Opto-Acoustic Image Quality With the Gen 2 Imagio System

This study performs the first clinical evaluation of the Gen 2 Imagio System in a clinical setting to assess image quality with both the IUS ultrasound only probe and the OA/US (duplex probe).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

UT Health

San Antonio, Texas, 78229, United States

About this study

  • Obtain ultrasound only probe images and duplex probe OA/US (both gray scale and OA) probe images. This includes doppler and elastography imaging with the gray scale only ultrasound probe and ultrasound mode of the duplex OA/US probe.
  • Provide breast and lymph node pathology results (except BI-RADS 1, 2 and 3 (as applicable))

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Has a signed and dated informed consent, prior to initiation of any study-related activities.
  • Is at least 18 years of age.
  • Have been referred for a breast US because of a breast lesion/mass finding via a palpable lump or per standard of care imaging.
  • Is willing and able to comply with protocol-required scans

Exclusion criteria

  • Is pregnant or lactating.
  • Has a condition or breast impediment (i.e. insect bites, poison ivy, rash, open wounds, chafing of the skin, scar, tattoos, moles, hematoma, nipple rings, etc.) which could interfere with the intended field of view.
  • Is experiencing photo-toxicity associated with currently taking, or having taken, photosensitizing agents within the previous 72 hours such as some sulfur containing drugs, ampicillin, tetracycline.
  • Is currently undergoing phototherapy.
  • Has a history of any photosensitive disease (e.g., porphyria, lupus erythematosus) or undergoing treatment for a photosensitive disease and is experiencing photosensitivity.
  • Has had an adverse reaction in the past to medical laser procedures, such as laser hair removal or laser tattoo removal.
  • Has had prior benign excisional breast biopsy on breast of interest within the past 18 months.
  • Currently has mastitis.
  • Prisoners

Treatment and study plan

Imagio

Device

Imagio - both ultrasound probe and Duplex OA probe

Primary outcomes

  1. Number of Participants With Imagio Image Sets Collected

    Time frame: Baseline

    Obtain ultrasound only probe images and OA/US (both gray scale and OA) probe images as measured by the receipt of image sets for each subject enrolled.

  2. Number of Subjects With Completed Pathology Results

    Time frame: Baseline

    Provide breast pathology results per subject (except BI-RADS 1, 2 and 3 (as applicable)) if subject's study mass is biopsied

Sponsors and collaborators

Lead sponsor

Seno Medical Instruments Inc.

Industry

Collaborators

  • American College of Radiology

Registry information

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Aug 26, 2021
Registry last updated
Mar 29, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.